189 results on '"Ukimura A"'
Search Results
2. Effect of the introduction of a management bundle for blood culture collection.
- Author
-
Minami, Kenta, Yamada, Tomoyuki, Yoshioka, Kyouhei, Kawanishi, Fumiko, Ogawa, Taku, and Ukimura, Akira
- Abstract
• Adherence to blood culture bundle can reduce contamination rate. • Less contamination when collected from superficial veins of the cubital fossa. • Using chlorhexidine alcohol reduced contamination. Inappropriate blood collection subjected to blood culture (BC) causes BC contamination and may complicate the diagnose is of infectious diseases. Therefore, we developed a bundle based on the guideline recommendations for appropriate blood collection and examined the effects of bundle introduction. We performed a retrospective analysis of BC samples to determine the contamination rates before and after introducing the BC bundle. We also analyzed the correlation between the compliance rate of the bundle and contamination rate, and between each bundle element and contamination. After the introduction of the bundle, the contamination rate was significantly reduced from 5.4% ± 0.9% to 1.7± 0.7% (P <.01). The compliance rate of the bundle was significantly associated with a lower contamination rate (P <.01). Multivariable logistic regression showed that collection from superficial veins of the cubital fossa (odds ratio [OR], 0.25; 95% confidence interval [CI], 0.13-0.51, P <.01) and disinfection of the skin at the blood collection site with 1% chlorhexidine alcohol swab (OR, 0.41; 95% CI, 0.25-0.68, P <.01) were significantly associated with lower contamination. This study suggests that the introduction of the BC bundle significantly reduced the contamination rate, and bundle compliance was associated with a lower contamination rate. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Detection of relatively poor but definitive blood supply in prostate stromal sarcoma using transrectal ultrasonography with superb microvascular imaging.
- Author
-
Ohashi, Munehiro, Shiraishi, Takumi, Fujihara, Atsuko, Yamada, Takeshi, Ueda, Takashi, Hongo, Fumiya, and Ukimura, Osamu
- Published
- 2022
- Full Text
- View/download PDF
4. PD39-12 FOLLOW-UP MODALITIES AFTER FOCAL THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER: MRI, CEUS, PSA, AND BIOPSY.
- Author
-
Kaneko, Masatomo, Ramacciotti, Lorenzo Storino, Paralkar, Divyangi, Ghoreifi, Alireza, Peretsman, Samuel, Brooks, Jessica, Cacciamani, Giovanni E., Hopstone, Michelle, Aron, Manju, Ukimura, Osamu, Bahn, Duke, Gill, Inderbir S., and Abreu, Andre Luis
- Subjects
PROSTATE-specific antigen ,PROSTATE cancer ,MAGNETIC resonance imaging ,HIGH-intensity focused ultrasound ,DIGITAL rectal examination - Published
- 2024
- Full Text
- View/download PDF
5. PD30-11 EXTERNAL VALIDATION FOR A FULLY AUTOMATED URINE CYTOLOGY SUPPORT ARTIFICIAL INTELLIGENCE SYSTEM.
- Author
-
Kaneko, Masatomo, Harada, Yuki, Tsuji, Keisuke, Paralkar, Divyangi, Fujihara, Atsuko, Ueno, Kengo, Nakanishi, Masaya, Konishi, Eiichi, Takamatsu, Tetsuro, Horiguchi, Go, Teramukai, Satoshi, Ito-Ihara, Toshiko, Abreu, Andre Luis, and Ukimura, Osamu
- Subjects
ARTIFICIAL intelligence ,CYTOLOGY ,URINE - Published
- 2024
- Full Text
- View/download PDF
6. MP25-20 SALVAGE FOCAL THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: ONCOLOGIC CONTROL AND FUNCTIONAL OUTCOMES.
- Author
-
Kaneko, Masatomo, Ramacciotti, Lorenzo Storino, Paralkar, Divyangi, Cacciamani, Giovanni E., Hopstone, Michelle, Aron, Manju, Ukimura, Osamu, Gill, Inderbir S., and Abreu, Andre Luis
- Subjects
PROSTATE cancer ,SALVAGE therapy ,FUNCTIONAL status ,PROSTATE biopsy - Published
- 2024
- Full Text
- View/download PDF
7. MP25-05 IMPACT OF MRI VISIBILITY OF PROSTATE CANCER ON ONCOLOGICAL OUTCOMES IN FOCAL THERAPY.
- Author
-
Kaneko, Masatomo, Ramacciotti, Lorenzo Storino, Paralkar, Divyangi, Peretsman, Samuel, Brooks, Jessica, Cacciamani, Giovanni E., Hopstone, Michelle, Aron, Manju, Ukimura, Osamu, Gill, Inderbir S., and Abreu, Andre Luis
- Subjects
PROSTATE cancer ,MAGNETIC resonance imaging ,HIGH-intensity focused ultrasound ,CANCER prognosis - Published
- 2024
- Full Text
- View/download PDF
8. MP18-03 NOVEL DEVELOPMENT OF THE VISUAL UROFLOWMETRY USING COLOR LASER-LIGHT SHEETS.
- Author
-
Ajiki, Jun, Naitoh, Yasuyuki, Hamato, Tamaki, Aburatani, Shunya, Murata, Shigeru, and Ukimura, Osamu
- Subjects
BENIGN prostatic hyperplasia ,COLOR - Published
- 2024
- Full Text
- View/download PDF
9. MP05-09 A NOVEL METHOD TO IDENTIFY AGGRESSIVE PROSTATE CANCER WITH DNA-METHYLATION SIGNATURES FROM PROSTATE NEEDLE BIOPSY.
- Author
-
Kaneko, Masatomo, Sekino, Yohei, Li, Hongtao, Zhou, Xinyi, Jin, Mingda, Guo, Wei, Yang, Xiaojing, Bhasin, Jeffrey, Fujihara, Atsuko, Iwata, Tsuyoshi, Ramacciotti, Lorenzo Storino, Paralkar, Divyangi, Cacciamani, Giovanni E., Aron, Manju, Ukimura, Osamu, Gill, Inderbir S., Liang, Gangning, and Abreu, Andre Luis
- Subjects
PROSTATE biopsy ,NEEDLE biopsy ,PROSTATE cancer ,RECEIVER operating characteristic curves - Published
- 2024
- Full Text
- View/download PDF
10. PCA3controls chromatin organization and p53 signal activation by regulating LAP2α-lamin A complexes
- Author
-
Ito, Saya, Ueda, Takashi, Yokoyama, Atsushi, Fujihara, Atsuko, Hongo, Fumiya, and Ukimura, Osamu
- Abstract
Prostate cancer antigen 3 (PCA3) is a prostate cancer-specific long noncoding RNA (lncRNA). Here, we report that lncRNA PCA3plays a role in prostate cancer progression that is mediated by nucleoplasmic lamins. PCA3interacts with the C-terminal region of lamina-associated polypeptide (LAP) 2α. The C-terminal region of LAP2α includes tumor suppressor protein retinoblastoma (pRb)- and lamin-binding domains, and it is necessary for the regulation and stabilization of the nucleoplasmic pool of lamin A. PCA3inhibits the interaction of LAP2α with lamin A through binding with the C-terminus of LAP2α. The level of nucleoplasmic lamin A/C is increased by knockdown of PCA3. Together, the level of LAP2α within the nucleus is increased by PCA3knockdown. In PCA3knockdown cells, the levels of HP1γ, trimethylation of Lys9 on histone H3 (H3K9me3), and trimethylation of Lys36 on histone H3 (H3K36me3) are upregulated. In contrast, trimethylation of Lys4 on histone H3 (H3K4me3) is downregulated. We further demonstrate that activation of the p53 signaling pathway and cell cycle arrest are promoted in the absence of PCA3. These findings support a unique mechanism in which prostate cancer-specific lncRNA controls chromatin organization via regulation of the nucleoplasmic pool of lamins. This proposed mechanism suggests that cancer progression may be mediated by nuclear lamins.
- Published
- 2022
- Full Text
- View/download PDF
11. Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol
- Author
-
Yamada, Yasuhiro, Shiaishi, Takumi, Ueno, Akihisa, Kaneko, Masatomo, Inoue, Yuta, Fujihara, Atsuko, Hongo, Fumiya, and Ukimura, Osamu
- Abstract
Whole-gland therapy for prostate cancer, which might cause more harm than no therapy (observation or active surveillance), might be a overtreatment. In order to avoid overtreatment as well as undertreatment of localize prostate cancer, novel strategy of organ-preserving therapies have been developed to achieve both cancer control and functional preservation. For the therapeutic techniques, microwave ablation would be an option for lesion-targeted focal therapy to eradicate biopsy-proven cancer lesion with its safety margin. Following our recent pilot clinical study of lesion-targeted focal cryotherapy, prospective clinical trial was designed to investigate the safety and therapeutic effects of lesion-targeted microwave therapy for localized prostate cancer.
- Published
- 2024
- Full Text
- View/download PDF
12. MRGBP promotes AR-mediated transactivation of KLK3 and TMPRSS2 via acetylation of histone H2A.Z in prostate cancer cells.
- Author
-
Ito, Saya, Kayukawa, Naruhiro, Ueda, Takashi, Taniguchi, Hidefumi, Morioka, Yukako, Hongo, Fumiya, and Ukimura, Osamu
- Abstract
Abstract The androgen receptor (AR) promotes growth of prostate cancer cells by controlling the expression of target genes. This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. We first showed that MRGBP promoted growth of AR-positive prostate cancer cells. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2 , and it associated with AR binding regions of these genes during androgen treatment. Furthermore, MRGBP interacted with MRG15 and TIP60 in prostate cancer cells. Androgen-stimulated AR enhanced histone H3K4me1 or H3K4me3 levels at AR binding regions. MRGBP was recruited to active gene regions through its binding with H3K4me1/3 by MRG15. Then, MRGBP promoted recruitment of TIP60 and acetylation of histone variant H2A.Z at the location of AR binding. Accordingly, AR occupancy of the AR binding regions was increased by MRGBP. Together, these results suggest that MRGBP promotes activation of AR-associated enhancer and promoter regions through an epigenetic mechanism. Highlights • Growth of prostate cancer cells was promoted by MRGBP. • MRGBP increased the expression levels of AR target genes in prostate cancer cells. • MRGBP was recruited to AR binding regions by associating with histone H3K4me1/3 upon androgen stimulation. • MRGBP promoted both the recruitment of TIP60 and the acetylation of histone H2A.Z at AR binding regions. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Evaluation of the safety and effectiveness of cryoablation in the treatment of renal angiomyolipoma related to tuberous sclerosis complex: The Cryo-TSC.
- Author
-
Kashiwagi, Eiji, Hatano, Takashi, Shimiz, Kanichiro, Takamoto, Atsushi, Tomita, Koji, Osawa, Takahiro, Sakuhara, Yusuke, Hongo, Fumiya, Hirota, Tatsuya, Ushijima, Yasuhiro, Asayama, Yoshiki, Miki, Jun, Kiyomi, Fumiaki, Egawa, Shin, Nasu, Yasutomo, Shinohara, Nobuo, Ukimura, Osamu, Nakano, Shuji, Arai, Yasuaki, and Eto, Masatoshi
- Published
- 2023
- Full Text
- View/download PDF
14. Identifying aggressive prostate cancer foci using a DNA methylation classifier
- Author
-
Mundbjerg, Kamilla, Chopra, Sameer, Alemozaffar, Mehrdad, Duymich, Christopher, Lakshminarasimhan, Ranjani, Nichols, Peter, Aron, Manju, Siegmund, Kimberly, Ukimura, Osamu, Aron, Monish, Stern, Mariana, Gill, Parkash, Carpten, John, Ørntoft, Torben, Sørensen, Karina, Weisenberger, Daniel, Jones, Peter, Duddalwar, Vinay, Gill, Inderbir, and Liang, Gangning
- Abstract
Slow-growing prostate cancer (PC) can be aggressive in a subset of cases. Therefore, prognostic tools to guide clinical decision-making and avoid overtreatment of indolent PC and undertreatment of aggressive disease are urgently needed. PC has a propensity to be multifocal with several different cancerous foci per gland. Here, we have taken advantage of the multifocal propensity of PC and categorized aggressiveness of individual PC foci based on DNA methylation patterns in primary PC foci and matched lymph node metastases. In a set of 14 patients, we demonstrate that over half of the cases have multiple epigenetically distinct subclones and determine the primary subclone from which the metastatic lesion(s) originated. Furthermore, we develop an aggressiveness classifier consisting of 25 DNA methylation probes to determine aggressive and non-aggressive subclones. Upon validation of the classifier in an independent cohort, the predicted aggressive tumors are significantly associated with the presence of lymph node metastases and invasive tumor stages. Overall, this study provides molecular-based support for determining PC aggressiveness with the potential to impact clinical decision-making, such as targeted biopsy approaches for early diagnosis and active surveillance, in addition to focal therapy.
- Published
- 2017
- Full Text
- View/download PDF
15. Successful control of an outbreak of GES-5 extended-spectrum β-lactamase-producing Pseudomonas aeruginosa in a long-term care facility in Japan.
- Author
-
Kanayama, A., Kawahara, R., Yamagishi, T., Goto, K., Kobaru, Y., Takano, M., Morisada, K., Ukimura, A., Kawanishi, F., Tabuchi, A., Matsui, T., and Oishi, K.
- Abstract
Background: Little is known about multidrug-resistant Pseudomonas aeruginosa (MDRP) outbreaks in long-term care facilities (LTCFs).Aim: To describe an MDRP outbreak in an LTCF and to clarify risk factors for MDRP acquisition.Methods: Patients who were positive for MDRP at an LTCF from January 2013 to January 2014 were analysed. A descriptive analysis, a case-control study, and a microbiological analysis were performed.Findings: A total of 23 MDRP cases were identified, 16 of which were confirmed in sputum samples. Healthcare workers were observed violating hand hygiene procedures when performing oral, wound, and genital care. Nasogastric tube and oxygen mask use was associated with MDRP acquisition in the respiratory tract, which might have been confounded by poor hand hygiene. Sharing unhygienic devices, such as portable oral suction devices for oral care, and washing bottles and ointments for wound and genital care with inadequate disinfection could explain the transmission of MDRP in some cases. Isolates from 11 patients were found to be indistinguishable or closely related by pulsed-field gel electrophoresis and harbouring the blaGES-5 gene. Subsequent enhanced infection control measures were supported by nearby hospitals and a local public health centre. No additional cases were identified for a year after the last case occurred in January 2014.Conclusion: An outbreak of MDRP with an antimicrobial resistance gene, blaGES-5, occurred in a Japanese LTCF. It was successfully controlled by enhanced infection control measures, which neighbouring hospitals and a local public health centre supported. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
16. Can We Avoid a Systematic Biopsy in Men with PI-RADS 5? Reply.
- Author
-
Tafuri, Alessandro, Atsuko Iwata, Shakir, Aliasger, Tsuyoshi Iwata, Gupta, Chhavi, Sali, Akash, Sugano, Dordaneh, Mahdi, Abtahi Seyed, Cacciamani, Giovanni E., Kaneko, Masatomo, Cai, Jie, Ukimura, Osamu, Duddalwar, Vinay, Aron, Manju, Gill, Inderbir S., Palmer, Suzanne L., and Abreu, Andre Luis
- Subjects
MEDICAL personnel ,PROSTATE cancer ,BIOPSY ,MAGNETIC resonance imaging ,PROSTATE-specific antigen ,CANCER hormone therapy - Published
- 2022
- Full Text
- View/download PDF
17. Quel est l’intérêt de l’échographie 3D et fusion d’image IRM pour la détection du cancer de la prostate ?
- Author
-
Marien, A., De Castro Abreu, A., Gill, I., Villers, A., and Ukimura, O.
- Abstract
La stratégie thérapeutique du cancer de la prostate dépend des données histo-pronostiques obtenues à partir des biopsies prostatiques, qui peuvent être améliorées par les biopsies dirigées (BD) en échographie transrectale 3D (ETR 3D) avec fusion élastique d’image IRM.
- Published
- 2017
- Full Text
- View/download PDF
18. Robotic Level III Inferior Vena Cava Tumor Thrombectomy: Initial Series.
- Author
-
Gill, Inderbir S., Metcalfe, Charles, Abreu, Andre, Duddalwar, Vinay, Chopra, Sameer, Cunningham, Mark, Thangathurai, Duraiyah, Ukimura, Osamu, Satkunasivam, Raj, Hung, Andrew, Papalia, Rocco, Aron, Monish, Desai, Mihir, and Gallucci, Michele
- Subjects
VENA cava inferior ,RENAL cancer patients ,SURGICAL robots ,LYMPHADENECTOMY ,NEPHRECTOMY ,INTRAOPERATIVE care ,TUMORS - Abstract
Purpose Level III inferior vena cava tumor thrombectomy for renal cancer is one of the most challenging open urologic oncology surgeries. We present the initial series of completely intracorporeal robotic level III inferior vena cava tumor thrombectomy. Materials and Methods Nine patients underwent robotic level III inferior vena cava thrombectomy and 7 patients underwent level II thrombectomy. The entire operation (high intrahepatic inferior vena cava control, caval exclusion, tumor thrombectomy, inferior vena cava repair, radical nephrectomy, retroperitoneal lymphadenectomy) was performed exclusively robotically. To minimize the chances of intraoperative inferior vena cava thrombus embolization, an “inferior vena cava-first, kidney-last” robotic technique was developed. Data were accrued prospectively. Results All 16 robotic procedures were successful, without open conversion or mortality. For level III cases (9), median primary kidney (right 6, left 3) cancer size was 8.5 cm (range 5.3 to 10.8) and inferior vena cava thrombus length was 5.7 cm (range 4 to 7). Median operative time was 4.9 hours (range 4.5 to 6.3), estimated blood loss was 375 cc (range 200 to 7,000) and hospital stay was 4.5 days. All surgical margins were negative. There were no intraoperative complications and 1 postoperative complication (Clavien 3b). At a median 7 months of followup (range 1 to 18) all patients are alive. Compared to level II thrombi the level III cohort trended toward greater inferior vena cava thrombus length (3.3 vs 5.7 cm), operative time (4.5 vs 4.9 hours) and blood loss (290 vs 375 cc). Conclusions With appropriate patient selection, surgical planning and robotic experience, completely intracorporeal robotic level III inferior vena cava thrombectomy is feasible and can be performed efficiently. Larger experience, longer followup and comparison with open surgery are needed to confirm these initial outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
19. Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume.
- Author
-
Matsugasumi, Toru, Baco, Eduard, Palmer, Suzanne, Aron, Manju, Sato, Yoshinobu, Fukuda, Norio, Süer, Evren, Bernhard, Jean-Christophe, Nakagawa, Hideo, Azhar, Raed A., Gill, Inderbir S., and Ukimura, Osamu
- Subjects
PROSTATE cancer ,DIAGNOSIS ,PROSTATE cancer patients ,MAGNETIC resonance imaging of cancer ,PROSTATE biopsy ,ULTRASONIC imaging ,PROSTATECTOMY - Abstract
Purpose Multiparametric magnetic resonance imaging often underestimates or overestimates pathological cancer volume. We developed what is to our knowledge a novel method to estimate prostate cancer volume using magnetic resonance/ultrasound fusion, biopsy proven cancer core length. Materials and Methods We retrospectively analyzed the records of 81 consecutive patients with magnetic resonance/ultrasound fusion, targeted biopsy proven, clinically localized prostate cancer who underwent subsequent radical prostatectomy. As 7 patients each had 2 visible lesions on magnetic resonance imaging, 88 lesions were analyzed. The dimensions and estimated volume of visible lesions were calculated using apparent diffusion coefficient maps. The modified formula to estimate cancer volume was defined as the formula of vertical stretching in the anteroposterior dimension of the magnetic resonance based 3-dimensional model, in which the imaging estimated lesion anteroposterior dimension was replaced by magnetic resonance/ultrasound targeted, biopsy proven cancer core length. Agreement of pathological cancer volume with magnetic resonance estimated volume or the novel modified volume was assessed using a Bland-Altman plot. Results Magnetic resonance/ultrasound fusion, biopsy proven cancer core length was a stronger predictor of the actual pathological cancer anteroposterior dimension than magnetic resonance estimated lesion anteroposterior dimension (r = 0.824 vs 0.607, each p <0.001). Magnetic resonance/ultrasound targeted, biopsy proven cancer core length correlated with pathological cancer volume (r = 0.773, p <0.001). The modified formula to estimate cancer volume demonstrated a stronger correlation with pathological cancer volume than with magnetic resonance estimated volume (r = 0.824 vs 0.724, each p <0.001). Agreement of modified volume with pathological cancer volume was improved over that of magnetic resonance estimated volume on Bland-Altman plot analysis. Predictability was more enhanced in the subset of lesions with a volume of 2 ml or less (ie if spherical, the lesion was approximately 16 mm in diameter). Conclusions Combining magnetic resonance estimated cancer volume with magnetic resonance/ultrasound fusion, biopsy proven cancer core length improved cancer volume predictability. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
20. Predictive Value of Magnetic Resonance Imaging Determined Tumor Contact Length for Extracapsular Extension of Prostate Cancer.
- Author
-
Baco, Eduard, Rud, Erik, Vlatkovic, Ljiljana, Svindland, Aud, Eggesbø, Heidi B., Hung, Andrew J., Matsugasumi, Toru, Bernhard, Jean-Christophe, Gill, Inderbir S., and Ukimura, Osamu
- Subjects
PROSTATE cancer ,DIAGNOSIS ,PROSTATE cancer treatment ,PROSTATECTOMY ,RETROSPECTIVE studies ,MAGNETIC resonance imaging ,BIOPSY ,PROSTATE-specific antigen - Abstract
Purpose Tumor contact length is defined as the amount of prostate cancer in contact with the prostatic capsule. We evaluated the ability of magnetic resonance imaging determined tumor contact length to predict microscopic extracapsular extension compared to existing predictors of extracapsular extension. Materials and Methods We retrospectively analyzed the records of 111 consecutive patients with magnetic resonance imaging/ultrasound fusion targeted, biopsy proven prostate cancer who underwent radical prostatectomy from January 2010 to July 2013. Median patient age was 64 years and median prostate specific antigen was 8.9 ng/ml. Clinical stage was cT1 in 93 cases (84%) and cT2 in 18 (16%). Postoperative pathological analysis confirmed pT2 in 71 patients (64%) and pT3 in 40 (36%). We evaluated 1) in the radical prostatectomy specimen the correlation of microscopic extracapsular extension with pathological cancer volume, pathological tumor contact length and Gleason score, 2) the correlation between microscopic extracapsular extension and magnetic resonance imaging tumor contact length, and 3) the ability of preoperative variables to predict microscopic extracapsular extension. Results Logistic regression analysis revealed that pathological tumor contact length correlated better with microscopic extracapsular extension than the predictive power of pathological cancer volume (0.821 vs 0.685). The Spearman correlation between pathological and magnetic resonance imaging tumor contact length was r = 0.839 (p <0.0001). ROC AUC analysis revealed that magnetic resonance imaging tumor contact length outperformed cancer core involvement on targeted biopsy and the Partin tables to predict microscopic extracapsular extension (0.88 vs 0.70 and 0.63, respectively). At a magnetic resonance imaging tumor contact length threshold of 20 mm the accuracy for diagnosing microscopic extracapsular extension was superior to that of conventional magnetic resonance imaging criteria (82% vs 67%, p = 0.015). We developed a predicted probability plot curve of extracapsular extension according to magnetic resonance imaging tumor contact length. Conclusions Magnetic resonance imaging determined tumor contact length could be a promising quantitative predictor of microscopic extracapsular extension. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Cryoablation for Renal Cell Carcinoma.
- Author
-
Baba, Shiro, Ono, Yoshinari, Ukimura, Osami, and Gill, Inderbir S.
- Abstract
The aim of energy-based tissue ablative procedures for renal cell carcinoma is to achieve complete destruction of the cancer cells, targeting the entire visualized tumor with a surrounding margin of healthy renal parenchyma. Based on recent technological advances of cryodelivery systems and imaging technology, cryoablation has now been performed via open, laparoscopic, and percutaneous approaches worldwide. Because immediate pathological confirmation of complete cancer cell death with negative surgical margin is impossible in cryoablation of renal tumor, clinical long-term follow-up with meticulous imaging assessment and needle biopsy data is necessary to determine the oncological effi- cacy of cryoablation for renal cell carcinoma. Recently, the authors reported intermediate-term oncological follow-up data on 56 patients, of whom each completed a 3-year follow-up after laparoscopic renal cryoablation. Overall 3-year cancer-specific survival was 98%. The intermediate-term oncological data are encouraging for continued performance of renal cryoablation for renal cell carcinoma in carefully selected older patients with a small renal mass. Technically, the authors routinely attempt to extend the iceball at least 1 cm beyond the edge of the tumor to achieve the tumoricidal temperature within the entire extent of the tumor. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
22. Adverse events after administration of the first and second doses of messenger RNA-based COVID-19 vaccines in Japanese subjects aged 12–18 years
- Author
-
Ogawa, Taku, Yamada, Tomoyuki, Matsumoto, Yuki, Minami, Kenta, Kawanishi, Fumiko, Nakano, Takashi, and Ukimura, Akira
- Abstract
Objective Using a prospective observational design, we assessed adverse events (AEs) after COVID-19 vaccination in Japanese patients.Methods Two doses of the mRNA-1273 (SPIKEVAX®) or BNT162b2 (COMIRNATY®) vaccine were administered to participants aged 12 to 18 years, and AEs after each dose were recorded for 14 days. Data on the duration and nature (local vs. systemic) of AEs were collected using a questionnaire. Sex-based differences in AE frequency were also analyzed.Results After the first and second doses, 152 and 135 vaccinees were enrolled, respectively. After the first dose, fever (>37.1°C) occurred in 38.9% of males and 50.0% of females, whereas local pain occurred in 89.8% and 97.7% of males and females, respectively (only SPIKEVAX® was used as the first dose). After the second dose, fever (>37.1°C) occurred in 77.8% and 82.6% of males vaccinated with COMIRNATY® and SPIKEVAX®, respectively, and 82.6% of females (all received SPIKEVAX®). The local pain rates in these groups were 80.6%, 76.3%, and 100%, respectively. After the second dose, local pain, fever (>38.1°C) and headache were significantly more common in female participants, and the median symptom duration was 3 days.Conclusions AEs were more frequent after the second dose and in females.
- Published
- 2022
- Full Text
- View/download PDF
23. Prostate Swelling and Shift During High Intensity Focused Ultrasound: Implication for Targeted Focal Therapy.
- Author
-
Shoji, Sunao, Uchida, Toyoaki, Nakamoto, Masahiko, Kim, Hakushi, de Castro Abreu, Andre Luis, Leslie, Scott, Sato, Yoshinobu, Gill, Inderbir S., and Ukimura, Osamu
- Subjects
PROSTATE cancer treatment ,HIGH intensity lasers ,RETROSPECTIVE studies ,EDEMA ,ULTRASONIC imaging ,INTRAOPERATIVE care - Abstract
Purpose: We quantified prostate swelling and the intraprostatic point shift during high intensity focused ultrasound using real-time ultrasound. Materials and Methods: The institutional review board approved this retrospective study. Whole gland high intensity focused ultrasound was done in 44 patients with clinically localized prostate cancer. Three high intensity focused ultrasound sessions were required to cover the entire prostate, including the anterior zone (session 1), middle zone (session 2) and posterior zone (session 3). Computer assisted 3-dimensional reconstructions based on 3 mm step-section images of intraoperative transrectal ultrasound were compared before and after each session. Results: Most prostate swelling and intraprostatic point shifts occurred during session 1. The median percent volume increase was 18% for the transition zone, 9% for the peripheral zone and 13% for the entire prostate. The volume percent increase in the transition zone (p <0.001), peripheral zone (p = 0.001) and entire prostate (p = 0.001) statistically depended on the volume of each area measured preoperatively. The median 3-dimensional intraprostatic shift was 3.7 mm (range 0.9 to 13) in the transition zone and 5.5 mm (range 0.2 to 14) in the peripheral zone. A significant negative linear correlation was found between the preoperative presumed circle area ratio, and the percent increase in prostate volume (p = 0.001) and shift (p = 0.01) during high intensity focused ultrasound. Conclusions: We quantified significant prostate swelling and shift during high intensity focused ultrasound. Smaller prostates and a smaller preoperative presumed circle area ratio were associated with greater prostate swelling and intraprostatic shifts. Real-time intraoperative adjustment of the treatment plan impacts the achievement of precise targeting during high intensity focused ultrasound, especially in prostates with a smaller volume and/or a smaller preoperative presumed circle area ratio. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
24. Urge Perception Index of Bladder Hypersensitivity.
- Author
-
Fujihara, Atsuko, Ukimura, Osamu, Honjo, Hisashi, Iwata, Tsuyoshi, Ueda, Takeshi, Matsugasumi, Toru, Kamoi, Kazumi, Okihara, Koji, Kawauchi, Akihiro, and Miki, Tsuneharu
- Subjects
URINARY urge incontinence ,BLADDER diseases ,ALLERGIES ,SELF-evaluation ,OVERACTIVE bladder ,SEVERITY of illness index ,OUTPATIENT medical care - Abstract
Purpose: By analyzing bladder diaries with patient self-reported urinary perception grades, we developed the urge perception index, a quantitative measure of bladder hypersensitivity. We evaluated the impact of the urge perception index on the definition of overactive bladder severity. Materials and Methods: We retrospectively evaluated the records of 69 female patients who visited our outpatient clinic with the complaint of storage symptoms. Patients were asked to complete the overactive bladder symptom score and a 3-day bladder diary with self-reported grading of urinary perception on a range of 1 to 5 per void. Overactive bladder was diagnosed in 43 patients and nonoveractive bladder was diagnosed in 26. The urge perception index was defined as voided volume divided by the urinary perception grade at each void. Results: We analyzed 1,578 reported voids. According to the urinary perception grade, urge perception index values for overactive bladder were significantly lower than those for nonoveractive bladder (grades 1 to 4 p <0.001). The average ± SD urge perception index in 3-day bladder diaries was lower in overactive than in nonoveractive bladder cases (55 ± 28 vs 133 ± 73, p <0.0001). The most severe (lowest) single urge perception index value during the 3 days was significantly lower in patients with overactive than with nonoveractive bladder (mean 20 ± 12 vs 62 ± 40, p <0.0001). There were negative linear correlations of the urge perception index with total overactive bladder symptom scores (r = −0.598, p <0.0001) and with an urgency symptom score (r = −0.557, p <0.0001). Conclusions: The urge perception index, an integrated parameter of patient reported bladder perception and voided volume, could be promising to quantify the severity of overactive bladder or bladder hypersensitivity by bladder diary analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
25. Minimally Invasive Partial Nephrectomy for Single Versus Multiple Renal Tumors.
- Author
-
Abreu, Andre Luis de Castro, Berger, Andre K., Aron, Monish, Ukimura, Osamu, Stein, Robert J., Gill, Inderbir S., and Desai, Mihir M.
- Subjects
NEPHRECTOMY ,KIDNEY tumors ,PERIOPERATIVE care ,HEALTH outcome assessment ,LAPAROSCOPIC surgery ,COMPARATIVE pathology ,COHORT analysis ,RETROSPECTIVE studies ,TUMOR treatment - Abstract
Purpose: We report the perioperative outcomes of robotic/laparoscopic partial nephrectomy for multiple tumors at a single operative session. Outcomes were compared with those of a matched pair cohort treated with partial nephrectomy for a single renal tumor. Materials and Methods: We retrospectively reviewed a prospectively maintained database from 2001 to 2010 and identified 33 patients who underwent partial nephrectomy for multiple tumors. They were matched 1 to 1 with 33 patients treated with partial nephrectomy for a single tumor. The multiple and single groups were matched for dominant tumor size (3.2 and 3.3 cm, p = 0.61), patient age (60 and 57 years, p = 0.59) and baseline estimated glomerular filtration rate (79.7 and 91.8 ml per minute/1.73 m
2 , p = 0.11), respectively. Results: A total 114 tumors were excised, including 81 in the multiple cohort. There was a median of 2 tumors per kidney (range 2 to 6). In the multiple and single tumor groups estimated blood loss (250 and 235 ml, p = 0.46) and warm ischemia time (19 and 30 minutes, respectively, p = 0.18) were similar. Median operative time (300 vs 217 minutes, p = 0.002) and hospital stay (3 vs 1 days, p = 0.005) were longer in the multiple group. There were 2 conversions to laparoscopic radical nephrectomy per group. Overall, complications developed in 11 (33%) vs 7 patients (21%) treated with partial nephrectomy for multiple vs single tumors (p = 0.40). Median estimated glomerular filtration rate at discharge home was 62.8 vs 67.6 ml per minute/1.73 m2 in the multiple vs single tumor groups (p = 0.53). Histology confirmed malignancy in 82% and 67% of patients, respectively (p = 0.26). One recurrent tumor in the multiple group had a focal positive margin. Conclusions: Robotic/laparoscopic partial nephrectomy can be safely performed for multiple ipsilateral tumors with perioperative outcomes similar to those in patients with a solitary tumor. [Copyright &y& Elsevier]- Published
- 2013
- Full Text
- View/download PDF
26. 3-Dimensional Elastic Registration System of Prostate Biopsy Location by Real-Time 3-Dimensional Transrectal Ultrasound Guidance With Magnetic Resonance/Transrectal Ultrasound Image Fusion.
- Author
-
Ukimura, Osamu, Desai, Mihir M., Palmer, Suzanne, Valencerina, Samuel, Gross, Mitchell, Abreu, Andre L., Aron, Monish, and Gill, Inderbir S.
- Subjects
MEDICAL imaging systems ,THREE-dimensional imaging ,PROSTATE disease diagnosis ,BIOPSY ,MAGNETIC resonance imaging ,ULTRASONIC imaging ,GADOLINIUM - Abstract
Purpose: We determined the accuracy of the novel Urostation 3-dimensional transrectal ultrasound system (Koelis, La Tranche, France) for image based mapping biopsies in a prostate phantom. The system is capable of 1) registering the 3-dimensional location of each biopsy track in the 3-dimensional prostate volume data and 2) performing elastic image fusion of transrectal ultrasound with magnetic resonance imaging. Materials and Methods: We used 3 CIRS-053 prostate phantoms containing 3 hypoechoic lesions to perform ultrasound guided biopsy and 3 CIRS-066 phantoms (Computerized Imaging Reference Systems, Norfolk, Virginia) containing 3 isoechoic but magnetic resonance imaging visible lesions to perform magnetic resonance fusion guided biopsy. Three targeted biopsies were done per lesion. Each biopsy tract was injected with gadolinium based magnetic resonance contrast mixed with india ink. Phantoms were then subjected to 1 mm slice magnetic resonance imaging and serial step sectioning to assess the accuracy of targeted biopsy. Results: A total of 27 ultrasound guided biopsies were targeted into 9 hypoechoic lesions. All 27 biopsies (100%) successfully hit the target lesion. For hypoechoic lesions mean ± SD procedural targeting error was 1.52 ± 0.78 mm and system registration error was 0.83 mm, resulting in an overall error of 2.35 mm. Of the 27 magnetic resonance fusion biopsies 24 (84%) hit the lesion. For isoechoic lesions mean procedural targeting error was 2.09 ± 1.28 mm, resulting in an overall error of 2.92 mm. Conclusions: The novel, computer assisted, 3-dimensional transrectal ultrasound biopsy localization system achieved encouraging accuracy with less than 3 mm error for targeting hypoechoic and isoechoic lesions. The ability to register actual biopsy trajectory and perform elastic magnetic resonance/ultrasound image fusion is a significant advantage for future focal therapy application. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
27. Zero Ischemia Anatomical Partial Nephrectomy: A Novel Approach.
- Author
-
Gill, Inderbir S., Patil, Mukul B., de Castro Abreu, Andre Luis, Ng, Casey, Cai, Jie, Berger, Andre, Eisenberg, Manuel S., Nakamoto, Masahiko, Ukimura, Osamu, Goh, Alvin C., Thangathurai, Duraiyah, Aron, Monish, and Desai, Mihir M.
- Subjects
ISCHEMIA ,NEPHRECTOMY ,CHRONIC kidney failure ,GLOMERULAR filtration rate ,CREATININE ,RENAL cell carcinoma - Abstract
Purpose: We present a novel concept of zero ischemia anatomical robotic and laparoscopic partial nephrectomy. Materials and Methods: Our technique primarily involves anatomical vascular microdissection and preemptive control of tumor specific, tertiary or higher order renal arterial branch(es) using neurosurgical aneurysm micro-bulldog clamps. In 58 consecutive patients the majority (70%) had anatomically complex tumors including central (67%), hilar (26%), completely intrarenal (23%), pT1b (18%) and solitary kidney (7%). Data were prospectively collected and analyzed from an institutional review board approved database. Results: Of 58 cases undergoing zero ischemia robotic (15) or laparoscopic (43) partial nephrectomy, 57 (98%) were completed without hilar clamping. Mean tumor size was 3.2 cm, mean ± SD R.E.N.A.L. score 7.0 ± 1.9, C-index 2.9 ± 2.4, operative time 4.4 hours, blood loss 206 cc and hospital stay 3.9 days. There were no intraoperative complications. Postoperative complications (22.8%) were low grade (Clavien grade 1 to 2) in 19.3% and high grade (Clavien grade 3 to 5) in 3.5%. All patients had negative cancer surgical margins (100%). Mean absolute and percent change in preoperative vs 4-month postoperative serum creatinine (0.2 mg/dl, 18%), estimated glomerular filtration rate (−11.4 ml/minute/1.73 m
2 , 13%), and ipsilateral kidney function on radionuclide scanning at 6 months (−10%) correlated with mean percent kidney excised intraoperatively (18%). Although 21% of patients received a perioperative blood transfusion, no patient had acute or delayed renal hemorrhage, or lost a kidney. Conclusions: The concept of zero ischemia robotic and laparoscopic partial nephrectomy is presented. This anatomical vascular microdissection of the artery first and then tumor allows even complex tumors to be excised without hilar clamping. Global surgical renal ischemia is unnecessary for the majority of patients undergoing robotic and laparoscopic partial nephrectomy at our institution. [Copyright &y& Elsevier]- Published
- 2012
- Full Text
- View/download PDF
28. α-Melanocyte Stimulating Hormone Analogue AP214 Protects Against Ischemia Induced Acute Kidney Injury in a Porcine Surgical Model.
- Author
-
Simmons, Matthew N., Subramanian, Vairavan, Crouzet, Sebastien, Haber, Georges-Pascal, Colombo, Jose R., Ukimura, Osamu, Neilsen, Søren, and Gill, Inderbir S.
- Subjects
MSH (Hormone) ,ISCHEMIA ,KIDNEY injuries ,LABORATORY swine ,CREATININE ,GLOMERULAR filtration rate ,ENZYME-linked immunosorbent assay ,C-reactive protein - Abstract
Purpose: α-Melanocyte stimulating hormone protects kidneys against ischemia and sepsis induced acute kidney injury in rodents. We examined the efficacy of α-melanocyte stimulating hormone analogue AP214 to protect against acute kidney injury in higher vertebrates. Materials and Methods: We performed a prospective, blinded, randomized, placebo controlled study in 26 pigs. Laparoscopic technique was used for left nephrectomy and to induce complete warm ischemia in the right kidney for 120 minutes. AP214 (200 μg/kg intravenously) was administered daily on the day of surgery and for 5 days thereafter. Kidney function was measured for 9 days. We measured changes in serum creatinine, estimated glomerular filtration rate, serum C-reactive protein and urine interleukin-18. Results: In the placebo control and AP214 groups mean peak serum creatinine was 10.2 vs 3.92 mg/dl and the estimated glomerular filtration rate nadir was 22.9 vs 62.6 ml per minute per kg (each p = 0.001). Functional nadir occurred at 72 vs 24 hours in the control vs AP214 groups. Estimated glomerular filtration rate outcome on postoperative day 9 was 118 vs 156 ml per minute per kg in the control vs AP214 groups (p = 0.04). Conclusions: We noted a robust renoprotective effect of AP214. A similar AP214 effect may be observed in humans. Future research includes mechanistic studies in pigs and a phase II human clinical trial of AP214 in kidney transplant and partial nephrectomy populations. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
29. Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice.
- Author
-
Matsumoto, Chika, Hayashi, Tetsuya, Kitada, Kento, Yamashita, Chika, Miyamura, Masatoshi, Mori, Tatsuhiko, Ukimura, Akira, Ohkita, Mamoru, Jin, Denan, Takai, Shinji, Miyazaki, Mizuo, Okada, Yoshikatsu, Kitaura, Yasushi, and Matsumura, Yasuo
- Abstract
Intermittent hypoxia caused by sleep apnea is associated with cardiovascular disease. Chymase has been reported to play an important role in the development of cardiovascular disease, but it is unclear whether chymase is involved in the pathogenesis of left ventricular remodeling induced by intermittent hypoxia. The aim of this study was to evaluate the effect of a novel chymase inhibitor (NK3201) on hypoxia-induced left ventricular remodeling in mice. Male C57BL/6J mice (9 weeks old) were exposed to intermittent hypoxia or normoxia and were treated with NK3201 (10 mg/kg per day) or the vehicle for 10 days. Left ventricular systolic pressure showed no significant differences among all of the experimental groups. Exposure to intermittent hypoxia increased left ventricular chymase activity and angiotensin II expression, which were both suppressed by treatment with NK3201. Intermittent hypoxia also increased the mean cardiomyocyte diameter, perivascular fibrosis, expression of inflammatory cytokines, oxidative stress, and NADPH-dependent superoxide production in the left ventricular myocardium. These changes were all suppressed by NK3201 treatment. Therefore, chymase might play an important role in intermittent hypoxia-induced left ventricular remodeling, which is independent of the systemic blood pressure. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
30. Efficacy of a Novel Device for Assessment of Autonomic Sensory Function in the Rat Bladder.
- Author
-
Abouassaly, Robert, Liu, Guiming, Yamada, Yasuhiro, Ukimura, Osamu, and Daneshgari, Firouz
- Subjects
URINARY organs ,NERVOUS system ,LIDOCAINE ,FIBERS - Abstract
Purpose: We developed and tested the efficacy of an implantable bladder device which, when combined with the Neurometer®, can be used to assess fiber specific afferent bladder sensation in the rat. Materials and Methods: We developed an implantable bladder device that applies selective nerve fiber stimuli (250 Hz for small myelinated Aδ fibers and 5 Hz for unmyelinated C fibers) to the bladder mucosa in the rat to determine bladder sensory perception threshold values. We performed 3 experiments in 55 female Sprague-Dawley rats to examine the effects of our device on voiding habits, assess the interobserver reliability of the sensory perception threshold and determine the effects of intravesical administration of resiniferatoxin (Sigma®) and lidocaine on the sensory perception threshold. Results: Sensory perception threshold values obtained by 2 blinded, independent observers were not different from each other (p = 0.41). Sensory perception threshold values obtained at the 2 stimulation frequencies remained constant for at least 3 weeks after device implantation. A significant increase in sensory perception threshold values after resiniferatoxin instillation was noted at a stimulus frequency of 5 Hz (p = 0.02), whereas intravesical lidocaine led to an immediate increase in the sensory perception threshold at 250 and 5 Hz. Device implantation led to an early decreased voided volume and increased frequency of voids, although these parameters returned to normal after 4 days. Conclusions: Assessment of bladder afferent sensation with our newly developed device is feasible in rats. It provides sensory perception thresholds that appear to be fiber-type selective for autonomic bladder afferent nerves. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
31. Visual Analog Scale Questionnaire to Assess Quality of Life Specific to Each Symptom of the International Prostate Symptom Score.
- Author
-
Ushijima, So, Ukimura, Osamu, Okihara, Koji, Mizutani, Yoichi, Kawauchi, Akihiro, and Miki, Tsuneharu
- Subjects
URINARY incontinence ,URINARY organs ,URINATION disorders ,PROSTATE - Abstract
Purpose: We assessed patient quality of life specific to each of the 7 items on the International Prostate Symptom Score, as evaluated with a novel visual analog scale questionnaire. Materials and Methods: A total of 246 male patients with a chief complaint of lower urinary tract symptom were asked to complete the International Prostate Symptom Score and visual analog scale questionnaires to assess bother or satisfaction regarding patient quality of life specific to each of the 7 items on the International Prostate Symptom Score. Results: An item with the maximum visual analog scale measure matched the chief complaint in 169 patients (69%). In contrast, the chief complaint failed to match to an item with the most severe International Prostate Symptom Score in 104 patients (42%) (p = 0.012). Multiple regression analysis to define the best predictor of International Prostate Symptom Score quality of life score of the 14 items, including International Prostate Symptom Score and visual analog scale, revealed that the best predictor was the visual analog scale measure for nocturia (p = 0.0003), followed by visual analog scale measures for frequency (p = 0.0004) and incomplete emptying (p = 0.01). After α-blocker treatment improvement in the visual analog scale measure for the chief complaint correlated better with improvement in the International Prostate Symptom Score quality of life score than the change in International Prostate Symptom Score. The overall test-retest correlation for the visual analog scale questionnaire in 55 healthy elderly men and 44 patients with lower urinary tract symptoms was 0.772 and 0.742, respectively (p <0.00001). Conclusions: The novel visual analog scale measure of quality of life specific to each of the 7 items on the International Prostate Symptom Score has a significant impact on identifying the patient chief complaint as well as on patient specific quality of life. Our study supports the concomitant use of the International Prostate Symptom Score and visual analog scale questionnaires. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
32. Real-Time Transrectal Ultrasound Guidance During Nerve Sparing Laparoscopic Radical Prostatectomy: Pictorial Essay.
- Author
-
Ukimura, Osamu and Gill, Inderbir S.
- Subjects
MALE reproductive organs ,PROSTATE cancer ,MEDICAL imaging systems ,PROSTATECTOMY ,ULTRASONIC imaging - Abstract
Purpose: We report that real-time TRUS can visualize prostate/periprostatic anatomy and provide intraoperative navigation during nerve sparing LRP. Real-time TRUS navigation during radical prostatectomy, whether open or laparoscopic, is a novel application about which little is known. Materials and Methods: Transperitoneal LRP with TRUS guidance has been performed in 77 consecutive men since March 2003. Gray-scale ultrasound (7.5 MHz) and power Doppler ultrasound were used. Real-time TRUS monitoring was performed preoperatively, intraoperatively and immediately postoperatively. Emphasis was placed on identifying the neurovascular bundles, defining the prostate apex contour and evaluating the location and extent of any hypoechoic cancer nodules. Results: Intraoperative TRUS navigation appeared to be helpful for certain specific technical aspects of LRP, including 1) the identification of hypoechoic prostate cancer nodules, 2) precision during lateral pedicle transection and neurovascular bundle release, 3) calibrated, wider dissection at the site of suspected extracapsular extension of cancer nodules to achieve negative margins, 4) tailored dissection according to the individual prostate apex and (5) facilitation of posterior bladder neck transection for the novice. Real-time TRUS monitoring of the location of the laparoscopic scissors tip (hyperechoic spot) in regard to the safe dissection plane at the concerned anatomical site was feasible. Blood flow in the neurovascular bundles before, during and after nerve sparing LRP was documented. Conclusions: Real-time rectum based monitoring such as TRUS navigation has the potential to enhance intraoperative surgical precision during LRP. A pictorial essay highlighting the various aspects of intraoperative TRUS is presented. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
33. Real-Time Transrectal Ultrasound Guidance During Laparoscopic Radical Prostatectomy: Impact on Surgical Margins.
- Author
-
Ukimura, Osamu, Magi-Galluzzi, Cristina, and Gill, Inderbir S.
- Subjects
MALE reproductive organs ,PROSTATE ,CANCER patients ,PROSTATECTOMY - Abstract
Purpose: We evaluated whether intraoperative real-time TRUS navigation during LRP can decrease the incidence of positive surgical margins. Materials and Methods: Since March 2001, 294 patients with clinically organ confined prostate cancer undergoing LRP have been retrospectively divided into 2 groups, including group 1—217 who underwent LRP without TRUS from March 2001 to February 2003 and group 2—77 who have undergone LRP with TRUS since March 2003. Various baseline parameters were similar between the groups. Before March 2001 the senior surgeon had already performed more than 50 cases of LRP, thus, gaining reasonable familiarity with the technique. Results: Compared to group 1, group 2 had a significantly decreased rate of positive surgical margins in patients with pT3 disease (57% vs 18%, p = 0.002). Positive margin rates also decreased in our overall experience (29% vs 9%, p = 0.0002). Intraoperative TRUS correctly predicted pT2 and pT3 disease in 85% and 86% of patients, respectively. Of the 54 TRUS visualized hypoechoic lesions at sites corresponding to biopsy proven cancer extracapsular extension was suspected in 31, leading to a real-time recommendation of calibrated wider, site specific dissection to achieve negative surgical margins. Conclusions: Intraoperative TRUS monitoring during LRP allows individualized, precise dissection tailored to the specific prostate contour anatomy, thus, compensating for the muted tactile feedback of laparoscopy. In what is to our knowledge the initial experience real-time TRUS guidance significantly decreased the incidence of positive surgical margins during LRP. In the future this concept of rectum based, intraoperative real-time navigation may facilitate a more sophisticated performance of radical prostatectomy. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
34. Laparoscopic Partial Nephrectomy in Solitary Kidney.
- Author
-
Gill, Inderbir S., Colombo, Jose R., Moinzadeh, Alireza, Finelli, Antonio, Ukimura, Osamu, Tucker, Kay, Kaouk, Jihad, and Desai, Mihir
- Subjects
CANCER patients ,TUMORS ,RENAL cancer ,ISCHEMIA - Abstract
Purpose: We report our experience with LPN for tumor in a solitary kidney. Materials and Methods: Of 430 patients undergoing LPN since February 1999 at our institution 22 (5%) underwent LPN for tumor in a solitary kidney, as performed by a single surgeon. The laparoscopic technique that we used duplicated open principles, including hilar clamping, cold cut tumor excision and sutured renal reconstruction. Results: Mean tumor size was 3.6 cm (range 1.4 to 8.3, median 3 cm), median blood loss was 200 cc (range 50 to 500), warm ischemia time was 29 minutes (range 14 to 55), total operative time was 3.3 hours (range 2.2 to 4.5) and hospital stay was 2.8 days (range 1.3 to 12). Two cases (9%) were electively converted to open surgery. Pathological findings confirmed renal cell carcinoma in 16 patients (73%) with negative surgical margins in all those with LPN. Major complications occurred in 3 patients (15%) and minor complications developed in 7 (32%). Median preoperative and postoperative serum creatinine (1.2 and 1.5 mg/dl) and estimated glomerular filtration rate (67.5 and 50 ml per minute per 1.73 m
2 ) reflected a change of 33% and 27%, respectively, which appeared proportionate to the median amount of kidney parenchyma excised (23%). One patient (4.5%) required temporary hemodialysis. At a median followup of 2.5 years (range 0.5 to 4.5) cancer specific and overall survival was 100% and 91%, respectively. No patient with LPN had local or port site recurrence, or metastatic disease. Conclusions: LPN can be performed efficaciously and safely in select patients with tumor in a solitary kidney. To our knowledge we present the largest series in the literature. Advanced laparoscopic experience and expertise are necessary in this high risk population. [Copyright &y& Elsevier]- Published
- 2006
- Full Text
- View/download PDF
35. Targeted prostate biopsies for a histogram of the index lesion
- Author
-
Ukimura, Osamu and Gill, Inderbir S.
- Abstract
Knowledge of the three-dimensional location and contour of the clinically significant cancer (index cancer), and its proximity to the critical anatomical structures (such as prostate capsule, external sphincter, neurovascular bundle) has significant impact on preoperative and intraoperative decision-making during radical prostatectomy and focal therapy treatments.
- Published
- 2013
- Full Text
- View/download PDF
36. Management of the En Bloc Distal Ureter and Bladder Cuff During Retroperitoneoscopic Radical Nephroureterectomy.
- Author
-
Novick, Andrew C., Stephen Jones, J., Klein, Eric A., Rackley, Raymond, Ross, Jonathan H., Ukimura, Osamu, and Gill, Inderbir S.
- Abstract
Radical nephroureterectomy with resection of the en bloc distal ureter and bladder cuff is the gold standard treatment option for most patients with upper urinary tract transitional cell carcinoma (TCC). Recurrence at the distal ureter and/or peiureteral bladder mucosa in the presence of ipsilateral upper urinary tract urothelial carcinoma has clinical significance. This procedure involves radical nephrectomy and en bloc distal ureterectomy with 2- to 3-cm-diameter bladder cuff, with special care to prevent urine spillage. We describe here our pure laparoscopic technique using two suprapubic transvesical ports, with cystoscopic secured detachment and ligation of the en bloc bladder cuff and juxtavesical ureter. This laparoscopic technique duplicates established principles of open radical nephroureterectomy. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
37. Current progress on augmented reality visualization in endoscopic surgery
- Author
-
Nakamoto, Masahiko, Ukimura, Osamu, Faber, Kenneth, and Gill, Inderbir S.
- Abstract
Advancements in surgery are progressing at a rapid rate; however, there are still limitations, including the ability to accurately visualize the target organ, in particular during laparoscopic surgery. Augmented reality visualization is a novel technique that has been developed to allow the fusion of three-dimensional medical images, such as those from transrectal ultrasound or computed tomographyMRI, with live camera images in real-time. In this review, we describe the current advancements and future directions of augmented reality and its application to laparoscopic surgery.
- Published
- 2012
- Full Text
- View/download PDF
38. Focal therapy for the treatment of localized prostate cancer
- Author
-
Ward, John F., Rewcastle, John C., Ukimura, Osamu, and Gill, Inderbir S.
- Abstract
Prostate cancer is a complex disease entity that covers a wide prognosis spectrum. Prostate cancer treatment options do not match this spectrum well. Focal therapy is an active area of research that may allow us to better match treatment to prognosis across the prostate cancer spectrum.
- Published
- 2012
- Full Text
- View/download PDF
39. Intraprostatic targeting
- Author
-
Ukimura, Osamu, Faber, Kenneth, and Gill, Inderbir S.
- Abstract
The ability to accurately localize and target prostate cancer, whether for staging or future interventions, is an important concept in prostate cancer management. In this review, we describe the emerging technologies that allow for enhanced visualization and precise targeting of the prostate cancer.
- Published
- 2012
- Full Text
- View/download PDF
40. Innovations in prostate biopsy strategies for active surveillance and focal therapy
- Author
-
Ukimura, Osamu, Hung, Andrew J, and Gill, Inderbir S
- Abstract
Active surveillance and focal therapy for prostate cancer have been proposed as treatment alternatives for prostate cancer. In this review, we track the emerging technologies that will support the viability of such management strategies.
- Published
- 2011
- Full Text
- View/download PDF
41. Image-guided surgery in minimally invasive urology
- Author
-
Ukimura, Osamu
- Abstract
Image-guided surgery (IGS) is a new type of surgery in which indirect visualization of the surgical anatomy helps the surgeon to enable minimally invasive percutaneous, laparoscopic, or robotic-aided treatment more precisely and safely, to achieve complete tumor removal and sparing of the function of critical organs.
- Published
- 2010
- Full Text
- View/download PDF
42. Hand-Assisted Retroperitoneoscopic Radical Nephrectomy and Nephroureterectomy
- Author
-
Kawauchi, Akihiro, Fujito, Akira, Soh, Jintetsu, Ukimura, Osamu, Mizutani, Yoichi, and Miki, Tsuneharu
- Abstract
In laparoscopic operations for renal tumor and upper urinary-tract transitional-cell carcinoma (TCC), three approaches - the transperitoneal, retroperitoneal, and transperitoneal hand-assisted - have been reported. We have performed hand-assisted retroperitoneoscopic radical nephrectomy (RN) since 1999 and nephroureterectomy (NU) since 2000. The surgical techniques and the operative results of 95 cases of RN and 54 cases of NU are described and analyzed. These procedures were effective and safe for renal tumors and upper urinary-tract TCC.
- Published
- 2004
- Full Text
- View/download PDF
43. REAL-TIME TRANSRECTAL ULTRASONOGRAPHY DURING LAPAROSCOPIC RADICAL PROSTATECTOMY
- Author
-
UKIMURA, OSAMU, GILL, INDERBIR S., DESAI, MIHIR M., STEINBERG, ANDREW P., KILCILER, METE, NG, CHRISTOPHER S., ABREU, SIDNEY C., SPALIVIERO, MASSIMILIANO, RAMANI, ANUP P., KAOUK, JIHAD H., KAWAUCHI, AKIHIRO, and MIKI, TSUNEHARU
- Abstract
We describe the technical aspects of real-time transrectal ultrasound (TRUS) monitoring and guidance during laparoscopic radical prostatectomy (LRP). Furthermore, we describe the TRUS visualized anatomy of periprostatic structures during LRP.
- Published
- 2004
- Full Text
- View/download PDF
44. Hand Assisted Retroperitoneoscopic Nephroureterectomy: Comparison With the Open Procedure
- Author
-
KAWAUCHI, AKIHIRO, FUJITO, AKIRA, UKIMURA, OSAMU, YONEDA, KIMIHIKO, MIZUTANI, YOICHI, and MIKI, TSUNEHARU
- Abstract
We report our initial experience with hand assisted retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma and compared our results to those of a contemporary series of open nephroureterectomy.
- Published
- 2003
- Full Text
- View/download PDF
45. Prognostic Significance of a Combination of Soluble Fas and Soluble Fas Ligand in the Serum of Patients with Ta Bladder Cancer
- Author
-
Mizutani, Yoichi, Yoshida, Osamu, Ukimura, Osamu, Kawauchi, Akihiro, Bonavida, Benjamin, and Miki, Tsuneharu
- Abstract
Recurrence after transurethral resection is one of the major problems in the treatment of superficial bladder cancer. However, there are no potent prognostic markers for recurrence in superficial bladder cancer at present. As circulating soluble Fas (sFas) and soluble Fas ligand (sFasL) have been implicated in protection from Fas-mediated apoptosis against cancers and may interfere with immune surveillance against autologous cancers, sFas and sFasL in the serum of patients with Ta bladder cancer were evaluated as prognostic tumor markers for recurrence. The serum levels of sFas and sFasL were measured by an enzyme-linked immunosorbent assay. Patients with Ta bladder cancer with low serum levels of both sFas and sFasL had a significantly longer postoperative tumor-free interval than those with high serum level of either sFas or sFasL in the 3-year follow-up. There was no correlation between the serum levels of sFas and sFasL. The present study has demonstrated that elevated serum sFas or sFasL predicts early recurrence in patients with Ta bladder cancer. These findings suggest that the serum levels of sFas and sFasL can be used as a prognostic indicator for recurrence in patients with Ta bladder cancer, and that sFas and sFasL may independently inhibit Fas-mediated apoptosis.
- Published
- 2002
- Full Text
- View/download PDF
46. Synergistic Cytotoxicity and Apoptosis of JTE-522, a Selective Cyclooxygenase-2 Inhibitor, and 5-fluorouracil Against Bladder Cancer
- Author
-
MIZUTANI, YOICHI, KAMOI, KAZUMI, UKIMURA, OSAMU, KAWAUCHI, AKIHIRO, and MIKI, TSUNEHARU
- Abstract
Cyclooxygenase-2 (COX-2) is a key inducible enzyme involved in the production of prostaglandins that has been shown to induce apoptosis in various cancer cells. Several anticancer agents also mediate apoptosis and may share the common intracellular pathways leading to apoptosis. Since over expression of COX-2 has been demonstrated in bladder cancer, we reasoned that combination treatment with a COX-2 inhibitor and anticancer agents in bladder cancer cells may result in synergistic apoptosis. We examined whether the selective COX-2 inhibitor JTE-522 induces apoptosis in bladder cancer cells and whether JTE-522 may act synergistically with anticancer agents to achieve cytotoxicity and apoptosis in these cells.
- Published
- 2002
- Full Text
- View/download PDF
47. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells
- Author
-
Kawano, Hidehiko, Tsuji, Hajime, Nishimura, Hiromi, Kimura, Shinzo, Yano, Shingo, Ukimura, Naoki, Kunieda, Yasufumi, Yoshizumi, Masami, Sugano, Tatsuya, Nakagawa, Katsumi, Masuda, Haruchika, Sawada, Shohei, and Nakagawa, Masao
- Abstract
Serotonin (5-hydroxytryptamine, or 5-HT), released from activated platelets, not only accelerates aggregation of platelets but also is known to promote mitosis, migration, and contraction of vascular smooth muscle cells (VSMCs). These effects are considered to contribute to thrombus formation and atherosclerosis. The aim of this study was to investigate the effects of 5-HT on the expressions of coagulative and fibrinolytic factors in rat aortic endothelial cells. Endothelial cells were stimulated with various concentrations of 5-HT (0.1∼10 μM), and the expressions of tissue factor (TF), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), and tissue-type plasminogen activator (TPA) messenger RNAs (mRNAs) were evaluated by Northern blot analysis. The activities of TF and PAI-1 were also measured. TF and PAI-1 mRNA were increased significantly in a concentration- and time-dependent manner. However, TFPI and TPA mRNA expression did not change. The inductions of TF and PAI-1 mRNAs were inhibited by a 5-HT1/5-HT2 receptor antagonist (methiothepin) and a selective 5-HT2A receptor antagonist (MCI-9042). These results indicate that 5-HT increases procoagulant activity and reduces fibrinolytic activities of endothelial cells through the 5-HT2A receptor. It was concluded that the modulation of procoagulant and hypofibrinolytic activities of endothelial cells by 5-HT synergistically promotes thrombus formation at the site of vessel injury with the platelet aggregation, VSMC contraction, and VSMC proliferation.
- Published
- 2001
- Full Text
- View/download PDF
48. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells
- Author
-
Kawano, Hidehiko, Tsuji, Hajime, Nishimura, Hiromi, Kimura, Shinzo, Yano, Shingo, Ukimura, Naoki, Kunieda, Yasufumi, Yoshizumi, Masami, Sugano, Tatsuya, Nakagawa, Katsumi, Masuda, Haruchika, Sawada, Shohei, and Nakagawa, Masao
- Abstract
Serotonin (5-hydroxytryptamine, or 5-HT), released from activated platelets, not only accelerates aggregation of platelets but also is known to promote mitosis, migration, and contraction of vascular smooth muscle cells (VSMCs). These effects are considered to contribute to thrombus formation and atherosclerosis. The aim of this study was to investigate the effects of 5-HT on the expressions of coagulative and fibrinolytic factors in rat aortic endothelial cells. Endothelial cells were stimulated with various concentrations of 5-HT (0.1∼10 μM), and the expressions of tissue factor (TF), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), and tissue-type plasminogen activator (TPA) messenger RNAs (mRNAs) were evaluated by Northern blot analysis. The activities of TF and PAI-1 were also measured. TF and PAI-1 mRNA were increased significantly in a concentration- and time-dependent manner. However, TFPI and TPA mRNA expression did not change. The inductions of TF and PAI-1 mRNAs were inhibited by a 5-HT1/5-HT2receptor antagonist (methiothepin) and a selective 5-HT2Areceptor antagonist (MCI-9042). These results indicate that 5-HT increases procoagulant activity and reduces fibrinolytic activities of endothelial cells through the 5-HT2Areceptor. It was concluded that the modulation of procoagulant and hypofibrinolytic activities of endothelial cells by 5-HT synergistically promotes thrombus formation at the site of vessel injury with the platelet aggregation, VSMC contraction, and VSMC proliferation.
- Published
- 2001
- Full Text
- View/download PDF
49. Follow-up study of bedwetting from 3 to 5 years of age
- Author
-
Kawauchi, A., Tanaka, Y., Yamao, Y., Inaba, M., Kanazawa, M., Ukimura, O., Mizutani, Y., and Miki, T.
- Published
- 2001
- Full Text
- View/download PDF
50. Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer
- Author
-
Nakanouchi, T., Okihara, K., Kojima, M., Ukimura, O., Yokoyama, K., Takamatsu, T., and Miki, T.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.